ATARA BIOTHERAPEUTICS WKN: A1166A ISIN: US0465131078 Forum: Aktien Thema: Hauptdiskussion

Nichts,es hat jemand teuer gekauft. Nachbörslich knapp 5% hoch bei nur 10k Volumen also wertlos.

Hoppla… Wasn da los?

Warum so bescheiden? 😁

Wir gehen einfach davon aus das Dollar und Bla kommt und fertig 🥳

Our existing cash, cash equivalents and short-term investments as of March 31, 2024 will not be sufficient to fund our planned operations for at least the next 12 months after the date of issuance of these financial statements. These conditions raise substantial doubt about our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements. In order to complete the process of obtaining regulatory approval for any of our product candidates that have not received approval, we will require substantial additional funding. We expect to continue to opportunistically seek access to additional funds through additional public or private equity offerings or debt financings, through potential collaboration, partnering or other strategic arrangements, or a combination of the foregoing. If we are unable to obtain sufficient funding on acceptable terms, we could be forced to delay, limit, reduce or terminate preclinical studies, clinical studies or other development activities for one or more of our product candidates. https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318306433&type=HTML&symbol=ATRA&cdn=f6a7319ec429e8c6eef470c23f64c4f6&companyName=Atara+Biotherapeutics+Inc.&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2024-05-09 Seite 34 wenn du auf vereinfachte Ansicht gehst.

Was heißt das glaube ich so nicht? Es steht doch im 10k Filing, ich habe mir das ja nicht ausgedacht.🤣